Print Page | Sign In | Join Today
VABIO E-News December 17, 2014
Share |
Email not looking beautiful? View it in your browser

Become a Member

VABIO E-News: December 17, 2014 Edition

Focus Around Virginia 
A Word from CEO Jeff Gallagher

Members and friends of Virginia Bio,

Participating in the process of public policy formation is a year round non-stop endeavor.

You may have noticed in the press that on December 4 the Governor hosted a roundtable on the commercialization of university bioscience research, the first event in a biotech initiative he announced to support the industry and determine public policy changes that will help. Virginia Bio was pleased to be an important resource to the Administration in planning this important event. MIT’s Robert Langer provided insights and inspiration. Highlights and insights from seven successful and varied university commercialization programs and experiences across the state were presented - what’s worked, what barriers remain, and what are the opportunities ahead. There was wide-ranging Q&A and discussion with the Governor and four Secretaries in his Administration. Working groups are forming to continue the discussion and evaluation, and make specific recommendations for changes which would make Virginia the best state in the nation for commercializing university bioscience research. The Governor has asked for the recommendations to be delivered to him in April, at Virginia Bio’s April 23 statewide conference; more conference information below. 

Of course some seasons of the year are a little busier than others. State public policy is about to get really busy as the 2015 Session of the General Assembly kicks off on January 14. This being an odd calendar year and therefore the second year in a biennial budget, this year’s GA Session will be a short session, scheduled for 30 days but typically extended to 45 days.

For complete article click here.

Thank you to our Premium Partners

Chairman's Circle:


Gold Partners:

Silver Partners:

Virginia Tech Fralin Life Science Institute            VWR

In this issue
focus around Virginia
VABIO Articles
VABIO Community News
VABIO Anniversaries
VABIO Calendar


VABIO Community News 
VABIO Member Anniversaries 

VABIO Events
Virginia Bio Calendar


CIT Extends FY2015 Solicitation For CRCF Deadline

The Center for Innovative Technology (CIT) opened solicitation on November 14, 2014 for the Commonwealth Research Commercialization Fund (CRCF) Request for Proposals (RFP) for FY2015. The Letter of Intent (LOI) deadline has been extended to noon on Friday, December 19, 2014 and the complete application due Friday, January 30, 2015. Award announcements are planned for early June 2015.

For complete article click here.

Governor’s Initiates New Virginia Economy Bioscience Initiative

Governor Terry McAuliffe has kicked off a new Virginia Bioscience Initiative with a public and private sector roundtable discussion on the commercialization of university bioscience research at the State Capitol. University representatives and bio industry leaders joined the Governor, members of his administration and renowned Massachusetts Institute of Technology Professor Dr. Robert S. Langer for this discussion.

For complete article click here.

Nancy Grden Appointed First Director of Strome Entrepreneurial Center

Nancy L. Grden, general manager for Genomind and a long-time entrepreneur, has been hired as the first executive director for Old Dominion University’s Strome Entrepreneurial Center, beginning in January.                        

For complete article click here.

Ampel BioSolutions Identifies Novel Lupus Treatments And Targets

Virginia researchers and founders of AMPEL BioSolutions, Drs. Amrie Grammer and Peter Lipsky delivered the results of a year-long Lupus Drug Repositioning Initiative this week in Boston. The Alliance for Lupus Research (ALR), the Lupus Research Institute (LRI) and AMPEL gathered with scientists at a key meeting of the American College of Rheumatology to launch the Lupus Clinical Investigators Network (LuCIN) of the LRxL-STAT Lupus Drug Repositioning Initiative.

For complete article click here.

Indoor Biotechnologies Secures New Facility

Indoor Biotechnologies will have a new space at 700 Harris Street in Charlottesville, VA with facilities that include advanced manufacturing capabilities for production of allergens and other biologics for the allergy diagnostics industry.

For complete article click here.

Ceres Receives $430K from Gates Foundation For Ebola Test Development

Ceres Nanosciences, Inc. (Ceres) commenced a development program, funded by the Gates Foundation, to use Ceres’ Nanotrap® particle technology to develop a new method of detecting the presence of the Ebola Virus in saliva. During the four month performance of this program, Ceres will work in close collaboration with George Mason University (Mason) and the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) to assess the ability of the Nanotrap technology to develop a more sensitive and safe Ebola virus detection method which uses saliva instead of blood.

For complete article click here.

Virginia Bio Welcomes Two New Members to its Board of Directors

Virginia Bio, the premier statewide non-profit trade association representing life sciences industry in the Commonwealth of Virginia, elected two new members to their Board of Directors for a term of three years. The election took place on December 11, 2014 at the Virginia Bio Annual Membership Meeting in Richmond, Virginia. The newly elected members include Charles Pennington, President of TechLab, Inc., and Carrie Roth, Executive Director of the Virginia Biotechnology Research Partnership Authority and President/CEO of the Virginia BioTechnology Research Park.

For complete article click here.

NPR Features HemoShear's Transformational Drug Discovery Approach

Dr. Moira Gunn, host of NPR's Tech Nation, sat down with Dr. Brian Wamhoff, co-founder and vice president of R&D at HemoShear, to discuss the importance of accurate human disease models for successful drug discovery. Dr. Wamhoff explains how HemoShear leverages its best-in-class human tissue disease models to uncover human disease biology and discover new drug treatments. "It's a whole new way of doing drug development," he says.

For complete article click here.

Elder Research In New Class Of HHS ‘Entrepreneurs-In-Residence’

As mentioned in the Washington Post, the Department of Health and Human Services began its third group of “entrepreneurs-in-residence”. These private-sector tech experts and start-up founders will be spending a year advising the agency on its IT projects.

Paula Braun, a data scientist with Elder Research, is embedded in the Centers for Disease Control and Prevention to devise a better Electronic Death Registration System, so that the CDC can refine its analytics and predictive modeling.

For complete article click here.

Robert T. Bohannon Joins Hunton & Williams Government Relations

Robert T. “Robb” Bohannon has joined Hunton & Williams LLP as Director of Government Affairs, resident in the Richmond office. With more than 10 years of experience in federal and state politics, representing trade associations in the medical, entertainment, and high tech industries, as well as a Virginia-based wellness company, Bohannon will advocate for clients on matters before state, county and city governments as a member of the firm’s state government relations team.

For complete article click here.

Comment On Regulation Of Innovative Diagnostic Tests By January 5th

The House Energy and Commerce Committee has released its latest white paper in the 21st Century Cures initiative. The paper solicits feedback regarding the regulation of in vitro diagnostic test kits and laboratory developed tests. All comments can be sent to by January 5, 2015.
For complete article click here.

Diffusion Wins Buzz Of BIO Most Promising Private Company

Virginia Bio would like to extend congratulations to Diffusion Pharmaceuticals, for receiving the BIO “Most Promising Private Company” award, presented at the 2015 CEO & Investor Conference.

For complete article click here.

Virginia Tech GenoSIGHT Software Improves Research

Synthetic biologists at the Virginia Bioinformatics Institute are at Virginia Tech pioneering new ways to overcome old problems in imaging cells. Using new software called GenoSIGHT, scientists were able to design a "smart" microscope capable of collecting time-lapse images of cells that would otherwise have been difficult to capture.

For complete article click here.

K2M Bringing 97 New Jobs To Loudoun County’s Leesburg

Governor Terry McAuliffe has announced that K2M Group Holdings, Inc., a global medical device company, will relocate its global headquarters and research and development operations to a new 146,000-square-foot facility in the Town of Leesburg in Loudoun County. The approximately $28 million project is expected to create 97 new jobs and retain 268 jobs, and will be funded through contributions from Trammell Crow Company, Keane Enterprises, Inc., and K2M, as well as the Town of Leesburg, Loudoun County, and the Commonwealth.

For complete article click here.

Make The Most Of San Francisco With Meeting Space And Reception

Virginia Bio, has arranged for quiet and attractive meeting room space steps away from Union Square in San Francisco during JP Morgan HealthCare conference week, January 12-14, 2015 to support our members in attendance. Virginia Bio members can reserve times for use of a room at the Handlery Union Square Hotel right now by visiting here. Reservations for meeting space will continue throughout the conference based on availability.

For complete article click here.

Welcome New Member: InnoSound
InnoSound Technologies Inc. was founded at the Biotechnology Research Park in Virginia. The company offers unique ultrasonic surgical products and their related services to global surgeons. These techniques reduce the difficulty for surgeons in precision surgeries and bring patients minimal injury.

InnoSound maintains good cooperation relations with universities, scientific research institutions and top-class hospitals in the world, so products can be quickly brought to market.

For more information please visit their website.

Welcome New Member: RagingWire Data Centers

In early 2000, George Macricostas and his father Constantine “Deno” Macricostas founded RagingWire Enterprise Solutions, now RagingWire Data Centers – because they wanted to design, build, and operate the world’s best data centers.

RagingWire’s Chief Engineer, Charlie Linkhart and the executive management team created RagingWire’s 2N+2 critical infrastructure architecture and N-Matrix™ infrastructure management systems in order to offer data centers without operation interruption during maintenance.

For more information please visit their website.

Welcome New Member: Vidrio Technologies

Vidrio Technologies launched in 2014 to provide software for imaging in brain science, mainly ScanImage and related tools.

ScanImage is widely used open-source software for laser scanning microscopy. ScanImage supports imaging of large populations of individual neurons and also allows drilling down to individual cells and synapses.

Vidrio is the Spanish word for “glass”. This reflects its origin as a spin-off from HHMI’s glass-encased Janelia Research Campus and its goal in providing a clear “window into the brain”.

For more information please visit their website.

VABIO Community News TO TOP

Governor Terry McAuliffe announced the appointment of Dr. Martin Lenhardt to his administration on November 21, 2014. Martin L. Lenhardt, Au.D., Ph.D. of Hayes, Professor of Biomedical Engineering (21 yrs.) and former Professor of Otolaryngology (23 yrs.), Virginia Commonwealth University was appointed to the Board of Audiology and Speech-Language Pathology. Lenhardt is CEO and President of Ceres Biotechnology, LLC in Richmond, founded as a university start-up in 2002, focusing on the development of acoustic technologies including personal sonars.
Dr. Kurt Newman, CEO, Children’s National Health System was named Washington Business Journal’s Most Admired CEO.

On November 1, 2014, ITL Virginia moved to a larger facility in Ashland, providing more office and workshop space for instrument servicing and marketing of its contract services. As a way of continued expansion into the US, the company is now implementing a Quality Management System for FDA compliance, allowing medical device manufacture to be undertaken at its US facility, in addition to its well established European and Far East locations.
VABIO Member Anniversaries TO TOP

Virginia Bio would like to thank our long term members who have recently celebrated their membership anniversaries:


Event: Virginia Bio Policy Briefing Conference Call

Where:  Conference Call
When: Monday, January 5, 3:00 pm - 4:00 pm
Details: Dial in to participate in this important conference call briefing from the comfort of your own office. This event is exclusively for Members of Virginia Bio and their employees only. Conference call information will be found on the registration confirmation page. You will also receive an email the day of the call containing the information to dial in.
  Click here to register

Event: Virginia Bio Commercialization Luncheon

Where:  Virginia Biotechnology Research Park, Richmond, VA
When: Thursday, January 8, 11:30 am - 1:30 pm
Title: Licensing biomedical technology - dispatches from the dealmakers
Registration:  Click here to register
Sponsors: Data Blueprint, Greater Richmond Partnership, McGuireWoods, VCU Innovation Gateway, We Work For Health and the Virginia Biotechnology Research Park

Event: Virginia Bio and Friends Reception in San Francisco
Where:  Eno Wine Bar, 320 Geary St, San Francisco, CA
When: Sunday, January 11, 4:00 pm - 7:00 pm
Details: Connect, reconnect and network while enjoying great wines, charcuterie and artisanal cheeses.
Also, use Virginia Bio's quiet, convenient suite for your 1:1 meetings with investors, partners and customers. Located at The Handlery Union Square.
Registration:  Click here to register.
Sponsors: Cary Street Partners, Center for Innovative Technology, Diffusion Pharmaceuticals, kaléo, Inc., Virginia Economic Development Partnership, Virginia Beach Economic Development

Event: VABIO Biotech and Beer Legislative Reception
Where: kaléo, Inc., Richmond, VA
When: Thursday, February 12, 5:00 pm - 7:00 pm
Details: Join the lively conversation at Biotech and Beer. Meet old friends and new colleagues in the life science community, along with state officials. Complimentary admission for all bioscience company employees, and university students and researchers with advanced registration. All others may purchase tickets.
Registration: Click here to register.
Sponsors: PhRMA

Event: Virginia Bio Commercialization Luncheon
Where:  Virginia Biotechnology Research Park, Richmond, VA
When: Thursday, February 19, 11:30 am - 1:30 pm
Title: Finding and Working with an Investment Banker (plus updates from January's 32nd Annual JP Morgan Health Care Conference).
Registration:  Click here to register
Sponsors: Data Blueprint, Greater Richmond Partnership, McGuireWoods, VCU Innovation Gateway, We Work For Health and the Virginia Biotechnology Research Park  

Event: Virginia Bio Commercialization Luncheon
Where: Virginia Biotechnology Research Park, Richmond, VA
When: Thursday, March 12 - 11:30 am - 1:30 pm
Title: Agricultural Bio: Biotechnology meets Virginia's largest industry.
Registration: Click here to register.
Sponsors: Data Blueprint, Greater Richmond Partnership, McGuireWoods, VCU Innovation Gateway, We Work For Health and the Virginia Biotechnology Research Park  

Virginia Bio, was formed in 1992 and incorporated in the Commonwealth of Virginia as a non-profit association. The purpose of the Association is to promote the biotechnology industry in Virginia, expand the knowledge and expertise of Virginia's businesses concerning biotechnology through seminars, educational publications and other means, to enhance public awareness of the biotechnology industry in Virginia and the scientific, economic and other benefits it provides, and to represent the interests of the biotechnology industry in Virginia before federal, state and local legislators and regulators.  We provide a forum for members and their guests to get to know each other and the many bioscience companies operating today in Virginia and serving our biotech community. We coordinate information among the many agencies and organizations interested in biotechnology.

To learn more about Virginia Bio and how you can get involved, Click Here

This is the E-newsletter of Virginia Bio, a non-profit organization dedicated to supporting the Life Sciences community in the Commonwealth of Virginia. New subscribers can join at our website,  
This email was sent to '' from Virginia Bio. If you wish to stop receiving email from us, you can simply remove yourself by clicking here.
 In order to continue receiving emails from Virginia Bio, please add to your safe sender list.

Our Premium Partners

Sign up for our newsletter
800 E. Leigh St.  |  Richmond, Va 23219-1534  |  PH: 804.643.6360  |  Email Us
Stay Connected